ICON Announces Pricing of USD 2 Billion Notes

Contributed by: Business Wire

Logo

Tags

Technology

Clinical Trials

Health Technology

Software

Biotechnology

Other Health

Internet

Health

Data Management

Pricing of USD 2 Billion Notes

More Like This

ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

ICON Issues Financial Guidance for Full Year 2024

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

ICON Reports First Quarter 2024 Results

ICON Reports Third Quarter 2025 Results

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON